Faeth Therapeutics Acquired by Sensei Biotherapeutics — Healthcare M&A

Sensei Biotherapeutics has completed the acquisition of Faeth Therapeutics, a healthcare services other business in the United States, for $200 million. Sensei Biotherapeutics acquisitions expand its healthcare M&A footprint by adding Faeth Therapeutics capabilities in biotherapeutics development and related services. Faeth Therapeutics supports translational research and therapeutic pipeline execution, strengthening Sensei’s strategic acquisition strategy in healthcare services other. The merger acquisition is announced and includes a concurrent $200 million private placement, with Sensei acting as a strategic buyer pursuing strategic acquisition synergies.